Blog
/blog
the-odin.comCrawled Oct 16, 2026
The page traces the history of human genome sequencing, from the $3 billion, 13-year project to an online $599 offering, covering Sanger and next-generation sequencing.
The company offers whole-genome sequencing at 30x coverage for $599, with FASTQ raw data, BAM aligned reads, and a VCF variant call file. The service covers humans and organisms with a published reference genome, with results in 2–3 weeks.
The company says it launched whole genome sequencing two days ago and received questions about how it handles genomic data before people made purchases.
The ODIN says genetic engineering and consumer genetic design will shape the future, and makes kits and tools for creating usable organisms at home, in a lab, or elsewhere.
Making Science and Genetic Engineering Accessible and Affordable
California enacts the first U.S. law restricting sales of home gene therapy kits amid concerns over unregulated genetic biohacking. The legislation targets consumer access to emerging, affordable genetic engineering tools now available for personal use. Officials cite risks from unsupervised applications of these technologies in household settings.
Citizen scientists are experimenting with gene editing tools like CRISPR outside regulated labs. Unverified DIY bio-hacking projects risk unintended genetic consequences, raising global safety concerns. Experts warn of potential long-term biological and ethical risks from unsupervised genetic modifications.
Scientists and bioethicists discuss the implications of widely available CRISPR gene-editing kits sold online. The tools enable nonprofessionals to experiment with DNA modification, raising concerns about safety and unintended consequences. Debates focus on whether the accessibility of CRISPR technology could lead to breakthroughs or pose risks without proper oversight.
Biohacker Josiah Zayner injects himself with a DNA-based solution to modify his muscle genes, aiming for muscle growth. The procedure is demonstrated at a gathering of synthetic biologists and researchers. Zayner presents the process as a self-administered genetic modification technique, though its safety and efficacy remain unverified.
Josiah Zayner sells CRISPR gene-editing kits for $150 through his company, The Odin, enabling individuals to access advanced synthetic biology tools. The venture operates out of a garage after Zayner left a NASA lab position. The Odin aims to democratize access to cutting-edge biotechnology for personal experimentation.